- Home
- KLXE vs CNTB Comparison
KLXE vs CNTB Comparison
Compare KLXE & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- CNTB
- Stock Information
- Founded
- KLXE 2018
- CNTB 2012
- Country
- KLXE United States
- CNTB United States
- Employees
- KLXE N/A
- CNTB N/A
- Industry
- KLXE Oilfield Services/Equipment
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- CNTB Health Care
- Exchange
- KLXE Nasdaq
- CNTB Nasdaq
- Market Cap
- KLXE 90.4M
- CNTB 68.5M
- IPO Year
- KLXE N/A
- CNTB 2021
- Fundamental
- Price
- KLXE $4.51
- CNTB $1.17
- Analyst Decision
- KLXE Hold
- CNTB Strong Buy
- Analyst Count
- KLXE 1
- CNTB 1
- Target Price
- KLXE $4.50
- CNTB $8.00
- AVG Volume (30 Days)
- KLXE 92.5K
- CNTB 24.6K
- Earning Date
- KLXE 11-04-2024
- CNTB 09-05-2024
- Dividend Yield
- KLXE N/A
- CNTB N/A
- EPS Growth
- KLXE N/A
- CNTB N/A
- EPS
- KLXE N/A
- CNTB N/A
- Revenue
- KLXE $769,700,000.00
- CNTB $24,116,000.00
- Revenue This Year
- KLXE N/A
- CNTB N/A
- Revenue Next Year
- KLXE $3.17
- CNTB $63.90
- P/E Ratio
- KLXE N/A
- CNTB N/A
- Revenue Growth
- KLXE N/A
- CNTB N/A
- 52 Week Low
- KLXE $4.18
- CNTB $0.68
- 52 Week High
- KLXE $12.13
- CNTB $2.84
- Technical
- Relative Strength Index (RSI)
- KLXE 33.44
- CNTB 44.02
- Support Level
- KLXE $4.31
- CNTB $1.18
- Resistance Level
- KLXE $4.59
- CNTB $1.26
- Average True Range (ATR)
- KLXE 0.31
- CNTB 0.07
- MACD
- KLXE -0.05
- CNTB -0.01
- Stochastic Oscillator
- KLXE 8.92
- CNTB 13.59
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.